Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 224 entries
View as:

Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05504148 Org: User:
Start: 03/29/21 End: 09/25/23 Due: 09/25/24

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Phase: N/A Priority: Normal
NCT ID: NCT06197724 Org: User:
Start: 01/02/24 End: 01/31/25 Due: 01/31/26

New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection

Phase: N/A Priority: Normal
NCT ID: NCT06355076 Org: User:
Start: 02/05/23 End: 06/30/26 Due: 06/30/27

Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06315699 Org: User:
Start: 03/20/24 End: 12/30/25 Due: 12/30/26

Effect of no Drainage Tube on Blood Loss and Recovery After High Tibial Osteotomy

Phase: N/A Priority: Normal
NCT ID: NCT03954860 Org: User:
Start: 08/01/18 End: 09/01/19 Due: 09/01/20

Evaluation of Antithrombotic STrategies in STEMI Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT03510832 Org: User:
Start: 03/01/18 End: 12/31/21 Due: 12/31/22

A Follow-up Study of Immune Dysregulation in Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05669248 Org: User:
Start: 01/03/23 End: 12/31/23 Due: 12/31/24

Diagnosis of Structural Heart Disease Using MCG

Phase: N/A Priority: Normal
NCT ID: NCT06315998 Org: User:
Start: 03/18/24 End: 09/30/25 Due: 09/30/26

21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT06891651 Org: User:
Start: 12/01/24 End: 12/31/34 Due: 12/31/35

Tongxinluo Capsule for Coronary Microvascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT04220372 Org: User:
Start: 01/31/20 End: 01/31/25 Due: 01/31/26

Early Management Strategies of Acute Heart Failure for Patients With NSTEMI

Phase: N/A Priority: Normal
NCT ID: NCT03189901 Org: User:
Start: 07/01/17 End: 12/31/21 Due: 12/31/22

Qishenyiqi Dripping Pill for Coronary Microvascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT06699420 Org: User:
Start: 11/08/23 End: 06/30/26 Due: 06/30/27

Antarctic Krill Oil for Knee Osteoarthritis Pain

Phase: N/A Priority: Normal
NCT ID: NCT06880926 Org: User:
Start: 04/01/25 End: 02/28/26 Due: 02/28/27

Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT06719037 Org: User:
Start: 12/08/24 End: 09/01/25 Due: 09/01/26

Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT06978205 Org: User:
Start: 04/28/25 End: 05/01/26 Due: 05/01/27

Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection

Phase: N/A Priority: Normal
NCT ID: NCT05625035 Org: User:
Start: 11/01/22 End: 12/31/23 Due: 12/31/24

Efficacy and Safety of Pirfenidone in CTD-ILD

Phase: N/A Priority: Normal
NCT ID: NCT05505409 Org: User:
Start: 06/22/22 End: 12/01/25 Due: 12/01/26

Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

Phase: N/A Priority: Normal
NCT ID: NCT06092736 Org: User:
Start: 12/18/18 End: 06/30/28 Due: 06/30/29

HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06239532 Org: User:
Start: 09/27/22 End: 12/31/25 Due: 12/31/26

Qishenyiqi for Ventricular Remodeling After Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT06699407 Org: User:
Start: 11/20/24 End: 12/31/27 Due: 12/31/28

Second-line Treatment of Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06242067 Org: User:
Start: 04/23/23 End: 12/31/26 Due: 12/31/27

Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06421220 Org: User:
Start: 05/20/24 End: 04/30/28 Due: 04/30/29

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06500247 Org: User:
Start: 07/31/24 End: 03/31/27 Due: 03/31/28

Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05410470 Org: User:
Start: 08/31/12 End: 12/31/21 Due: 12/31/22

Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05017922 Org: User:
Start: 01/01/17 End: 08/10/21 Due: 08/10/22